Rationale and Objectives: The purpose of this study is to compare image quality, presence and grade of artifacts, signal-to-noise ratio, and apparent diffusion coefficient (ADC) values in pancreatic tissue between high-resolution navigator-triggered (NT) restricted field of view (rFOV) FOCUS single-shot (SS) echo-planar imaging (EPI) diffusion-weighted imaging (DWI) and NT large FOV SS-EPI DWI.
D
iffusion-weighted imaging (DWI) initially found its applications in imaging of the brain in the 1980s and, in recent years, has become commonplace in body imaging to evaluate solid organs in both oncologic and nononcologic populations. 1 In particular, DWI is an evolving tool in evaluating pathologic conditions of the pancreas both qualitatively, by subjective evaluation of the images, and quantitatively, by measuring the apparent diffusion coefficient (ADC), a quantitative measure of water diffusivity. 2 Diagnostic accuracy of various diseases, in particular pancreatic tumors, has improved through the use of high resolution DWI and is reported by Ichikawa et al 1 as a means to detect pancreatic adenocarcinoma with high sensitivity and specificity. 3 Challenges to DWI of the pancreas remain, including its deep central location in the abdomen, far from the magnetic resonance imaging (MRI) coil elements 4, 5 and breathing motion. The susceptibility difference caused by metallic stents or surgical clips, and/or air in the adjacent stomach, transverse colon, and duodenum are a frequent source of image degradation resulting in both signal loss and spatial displacement of signal. [4] [5] [6] [7] Moreover, these inhomogeneity artifacts may alter ADC values.
Respiratory motion compensation is helpful in the acquisition of images of diagnostic quality and for visualizing fine anatomic details, as demonstrated in recent studies evaluating the image quality from respiratory-triggered, free-breathing, and breath-hold techniques for pancreatic adenocarcinoma. 4, [8] [9] [10] [11] [12] [13] [14] [15] Recently, reduced field of view (rFOV) FOCUS single-shot (SS) diffusion-weighted echo planar imaging (EPI) has been introduced with the potential of higher-resolution images in centrally located organs such as the prostate, spinal cord, and pancreas. 4, 6, [16] [17] [18] Several studies have demonstrated superior image quality, reduced artifacts, and improved identification of small anatomic structures such as the pancreatic ducts when comparing rFOV imaging of the pancreas to conventional large FOV due to higher spatial resolution. 3, 4, 8, 16, 17 In FOCUS, a 2-dimensional spatially selective echo-planar (in excitation k-space) radiofrequency excitation pulse reduces the excitation volume in both the phase encoding and slice select directions.
We hypothesized that a combination of rFOV FOCUS SS-EPI DWI with navigator echo respiratory triggering (NT) technique would allow for more robust and higher quality imaging compared with conventional large FOV SS-EPI DWI with NT.
The purpose of this study was to demonstrate the feasibility of high-resolution NT focus rFOV FOCUS SS-EPI DWI in patients and to compare image quality, presence, and grade of artifacts, signalto-noise ratio (SNR), and ADC values in pancreatic tissue between NT large FOV SS-EPI DWI and NT FOCUS rFOV SS-EPI DWI.
MATERIALS AND METHODS Patients
This retrospective study was approved by the local institutional review board committee. Images of 17 consecutive patients who underwent both large FOV and rFOV pancreas DWI with NT between August 2014 and January 2015 were reviewed. Magnetic resonance images were obtained from 17 consecutive patients (6 males and 11 females; mean age, 66.3 years; age range, between 47 and 81 years) undergoing magnetic resonance cholangiopancreatography (MRCP) with both large FOV and rFOV DWI (Fig. 1) . The patients were referred for MRCP for follow-up or initial evaluation of pancreatic cystic lesions (10 patients), staging/ characterization of pancreatic solid mass (4 patients), elevated liver function tests (1 patient), pancreatic cancer screening in subject with family history of pancreatic cancer (1 patient), and intrahepatic cholangiocarcinoma (1 patient).
MRI Technique
All MRI examinations were performed with GE 3-T systems (MR750, GE Healthcare, United States) using a 32-channel body array receive coil. Small shim volume was placed at the pancreas location for more accurate shimming. 
Image Analysis
A semiquantitative grading system was used to evaluate image quality and grade of artifacts. Presence of artifacts was assessed and, if present, subjectively rated for both large and rFOV DWI independently by 2 radiologists (with 9 and 10 years in abdominal MRI, respectively) with a 5-point scale (1, no artifacts present; 2, minimal artifacts, which do not interfere with diagnostic quality; 3, artifacts present which reduce diagnostic quality; 4, artifacts resulting in minimal diagnostic information; 5, nondiagnostic images). Image quality was subjectively rated by the same 2 radiologists with a 5-point scale (1, optimal image quality; 2, image of diagnostic image quality; 3, image of limited diagnostic value/quality; 4, only minimal diagnostic content in the images; 5, nondiagnostic images).
Overall image quality for both large and rFOV DWI was also subjectively rated by 2 radiologists in consensus on a 5-point scale (1, optimal image quality; 2, image of diagnostic image quality; 3, image of limited diagnostic value/quality; 4, only minimal diagnostic content in the images; 5, nondiagnostic images).
Signal-to-noise ratio and ADC were measured in the head, body, and tail of the pancreas on a dedicated workstation (GE Readyview; GE Healthcare, United States). Restricted field of view images do not include areas outside of the body, thus air could not be used for SNR calculation. Signal-to-noise ratio was calculated as the ratio between the average signal intensity and the standard deviation of the signal intensity within a 0.5-cm diameter manually placed circular regions of interest (ROIs) at the head, body, and tail of the pancreas on the b500 images over the tissue of interest taking care to avoid areas with artifacts, intraparenchymal vessels, and pancreatic duct. Apparent diffusion coefficient maps were calculated in a monoexponential fashion on a pixel-by-pixel basis to form ADC maps, with the gray scale of the pixel linearly corresponding to the ADC values. Mean ADC values (mm 2 /s) both at rFOV DWI and large FOV DWI were measured on ADC maps by manually placing 0.5 cm diameter circular ROIs at the head, body, and tail of the pancreas on the b50 DW images over the tissue of interest taking care to avoid areas with artifacts, intraparenchymal vessels, and pancreatic duct and copying and pasting the ROIs onto the ADC maps. Regions of interest were placed by a radiologist with 12 years of experience in abdominal MRI.
Statistical Analysis
Statistical analysis comparing the ADC and SNR values was performed using Student t test with differences considered significant FIGURE 1. b50 NT SS DW EPI rFOV (A) and b500 NT SS DW EPI rFOV (B) and b50 large FOV (C) and b500 large FOV (D) images acquired at the same level in the same patient show no significant difference in mean SNR distribution. In rFOV image (A) resolution, number of signal averages, and acquisition time are increased compared with large FOV image (B).
for P values less than 0.05. Wilcoxon signed rank test was performed to compare the scores on image qualities and artifacts, with differences considered significant for 2-tailed P less than 0.05. Interreader agreement on image quality and artifacts was assessed by calculating the interclass correlation coefficient.
RESULTS

Qualitative Analysis
Conventional large FOV and rFOV pancreas DWI with NT was feasible in all the subjects. Most of these patients were referred for follow-up of pancreatic cystic lesions, 11 whereas other reasons were evaluation of pancreatic solid masses, 4 cholangiocarcinoma, 1 and a family history of pancreatic cancer. 1 Presence of signal loss or ghosting artifacts within the pancreatic parenchyma was detected in 10 subjects, these were due to air in the colon (3 subjects), air in the stomach (3 subjects) (Fig. 2) , motion (1 subject), surgical clips (1 subject), surgical clips and air in the colon (1 subject), and motion and air in the colon (1 subject). Average artifact score was higher (3.06 ± 0.97) for large FOV compared with rFOV DW images (1.94 ± 0.75) (Fig. 1) , with a statistically significant difference between the 2 image datasets (P = 0.002). The 2 readers incidentally noted fewer and less severe susceptibility-induced artifacts with the rFOV sequence.
Overall image quality was subjectively higher for the rFOV with NT images (Fig. 2) with an average score of 1.94 ± 0.90 for rFOV and 3.00 ± 1.01 for conventional large FOV (P = 0.009).
Interreader agreement on image quality and artifacts was excellent k = 0.89 and k = 0.91, respectively. The consensus reading was not used for statistical analysis but was deemed necessary to eventually address discrepancies, because of the excellent agreement this was not needed.
Quantitative Analysis
Average SNR and ADC values are reported in Tables 1 and  2 . There was no significant difference in the SNR between the 2 image datasets (Fig. 1 ) (all P > 0.05, see Table 1 ) although the SNR was higher in the head and body compared with the tail in rFOV DWI.
The ADC values in the head, body, and tail of the pancreas were significantly lower when calculated from rFOV images compared with large FOV images ( Table 2) .
DISCUSSION
In our experience, combining rFOV pancreas FOCUS SS-EPI DWI with NT was feasible in all subjects and resulted in improved image quality and decreased artifacts compared with conventional large FOV SS-EPI DWI with NT. The average scan time for rFOV pancreas FOCUS SS-EPI DWI with NT was 3 minutes and 43 seconds.
Diffusion-weighted MRI has been used to characterize different pancreatic pathologic entities, such as cystic lesions, 19 neuroendocrine tumors, 20 pancreatitis, and pancreatic adenocarcinoma. 21 All of these studies have used qualitative assesment of images, and DWI has been proved to rise radiologist confidence in diagnosing these entities. Furthermore, ADC values allow a quantitive assement of different pathological processes, and there are promising results that allow to differetiate these processes based on their mean ADC values. For example, it has been described how chronic pancreatitis has lower ADC compared with normal pancreas, which may be explained by fibrosis and reduction of exocrine tissue. 22, 23 There are also different reports showing high sensitivity of DWI in detecteding pancreatic adenocarcinoma, 24, 25 although the specificity of ADC values for pancreatic adenocarcinoma detection is low due to some overlaps with values found in mass forming pancreatitis. 26, 27 Neuroendocrine pancreatic tumors show high signal intensity with high b-value DWI, probably because of their high cellularity and have ADC values lower than those of pancreatic adenocarcinoma. 20 Most of this literature agrees on how DWI can be useful for increasing confidence in visual detection of solid pancreatic tumors and how ADC measurements may help for differential diagnosis as a supplement to other imaging modalities. However, there is an agreement about many limitations of conventional DWI of the pancreas, so far addressed as low SNR, particulary on high b-values, and limited spacial resolution. Also motion artifacts have been addressed as potential cause of errors in ADC calculation. 28 In our clinical practice, patients being evaluated for pancreatic lesions undergo MRCP protocol. [29] [30] [31] The rationale for introducing a rFOV DWI focused on the pancreas is to provide higher spatial resolution to evaluate pancreatic solid and cystic lesions and to help delineate abnormalities in relation to the pancreatic duct. The higher spatial resolution has the potential for enhancing our ability to detect subtle solid lesions, augmenting our ability to discriminate benign from malignant lesions, and/or providing an improved means of monitoring tumor response to therapy. The Signal-to-noise ratio mean ± standard deviation values of the b500 DWI for the head, body, and tail of the pancreas for the large and restricted FOV. Student t test P values are reported in the third column.
rationale for introducing NT in rFOV DWI focused on the pancreas is to adress motion artifacts, improving ADC calculation.
Image quality scores were significantly higher in rFOV than in conventional large FOV DWI. The results of our study comparing artifacts and image quality are similar to those of another prior study, 4 with one main difference: our study combines both rFOV with NT technique whereas others evaluated these 2 factors independently. The improved image quality and reduction of artifacts demonstrates the potential benefits of this technique in future standard of pancreatic DWI.
The readers incidentally noted fewer and less severe susceptibility-induced artifacts with the rFOV sequence, we speculate that this could be due to the reduced echo train length (ETL) in the rFOV sequence resulting in reduced distortion by susceptibility artifact. For FOCUS SS-EPI DWI, a 2-dimensional spatially selective echo-planar (in excitation k-space) radiofrequency excitation pulse reduces the excitation volume in both the phase encoding and slice select directions and the ETL is equal to the phase matrix, in our case 80. For traditional DWI, ETL is equal to the phase matrix divided by the parallel imaging acceleration factor; in our case 64 (128 diveded 2).
We demonstrated that rFOV with NT is feasible in our patient population with no differences in SNR in the pancreatic head, body, and tail even with higher in-plane spatial resolution (Fig. 3) . This was achieved by increasing the number of excitations, with a 2-to 3-fold increase in acquisition time. The increase in spatial resolution has the potential to influence the differential diagnosis in clinical practice. For example, intraductal papillary mucinous neoplasm are more commonly multifocal compared with other cystic lesions of the pancreas; thus detection of additional lesions throughout the pancreas directs the differential diagnosis toward intraductal papillary mucinous neoplasm (Fig. 3) . [29] [30] [31] [32] [33] Navigator-triggered FOCUS rFOV SS-EPI has a smaller FOV and requires a longer acquisition time than NT large FOV SS-EPI DWI; these 2 sequences may either be integrated in the same protocol or, if NT FOCUS rFOV SS-EPI is used to replace large FOV SS-EPI DWI, the user needs to be aware that several areas of the upper abdomen, such as portions of the liver, spleen, spine, and kidneys, are not included in the FOV.
Lower ADC values for rFOV DWI compared with large FOV is of uncertain significance and is different from the findings of Ma et al. 4 Although we do not have a clear explanation for this finding, we speculate that the reason for a difference in ADC values is possibly a reduction in artifacts on DW images that may affect ADC maps calculation as reported in other studies. 6, 34 This has a potential clinical implication as prior large FOV DWI studies have shown mean ADCs of all pancreatic adenocarcinomas were significantly lower than that of the normal pancreatic tissues. Whether pancreatic adenocarcinoma would likewise demonstrate lower ADC values with rFOV DWI warrants further studies.
In our short series, the pancreas was always included in the planned single rFOV. However, FOCUS rFOV allows for a limited number of slices to be acquired, thus the craniocaudal extension of the pancreas may represent a limitation to this imaging approach. This can be overcome by using 2 consecutive rFOVs; with the 2 rFOVs including only the number of slices needed to cover the entire pancreas to keep the overall acquisition time within reasonable limits.
Our study has several limitations. First, the small sample size of patients undergoing both rFOV and large FOV with NT imaging was constrained by our retrospective study design, as rFOV DWI was available only on a fraction of our clinical scanners that underwent the requisite MRI scanner platform upgrades. Second, as noted previously, we used more signal averages for the rFOV DWI to compensate for the smaller voxel size due to smaller slice thickness, which resulting in comparable SNR to large FOV DWI. A more direct comparison of rFOV to large FOV DWI would have entailed similar values for all acquisition parameters, and would have increased the SNR of the latter. However, we did not have a clinical justification to scan our patients with a large FOV with a greater number of signal averages. A comparison in volunteers could have avoided this limitation, but would potentially be less informative than our study performed in actual patients. Third, the subset of patients studied were primarily an oncologic, outpatient population because of our referral pattern. Our results may not be applicable to an inpatient population due to acute issues such as abdominal pain, and potential irregular breathing, which might reduce the feasibility of a rFOV DWI with NT sequence, possibly resulting in more artifacts and decreased subjective image quality. Fourth, all MR examinations were performed on the MR system of 1 particular vendor and, therefore, our results may not be readily transferable across MR systems from other vendors. Finally, a potential clinical limitation of rFOV is the inability to assess for lesions outside its FOV; a radiologist would have to assess the need to perform both rFOV and large FOV DWI sequences when evaluating patients undergoing MRCP, or always get both with the resulting time costs.
In conclusion, our preliminary results show that both rFOV and large DWI with NT can be obtained with similar SNR, but that rFOV DWI demonstrates improved overall image quality with reduced artifacts (Fig. 4) . We incidentally noted that pancreatic DWI reduced ETL results in reduced distortion by susceptibility artifact. Improved image quality is likely to increase sensitivity and specificity; however, we have no data to support this yet.
